Monte Rosa Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NEA MANAGEMENT COMPANY, LLC | 02/17/2026 | 7.69 M | $120.62 M | 0.00% | 9.34% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 5.12 M | $80.27 M | 10.39% | 6.21% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/17/2026 | 4.62 M | $72.48 M | 100.00% | 5.61% |
| VERSANT VENTURE MANAGEMENT, LLC | 02/12/2026 | 4.38 M | $68.72 M | -22.47% | 5.32% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 4.35 M | $68.14 M | -11.60% | 5.27% |
| BLACKROCK, INC. | 02/12/2026 | 4.18 M | $65.56 M | 9.59% | 5.07% |
| BVF INC/IL | 02/17/2026 | 3.84 M | $60.15 M | -32.23% | 4.66% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/17/2026 | 3.36 M | $52.68 M | 0.00% | 4.08% |
| VANGUARD GROUP INC | 01/29/2026 | 3.25 M | $50.91 M | 8.62% | 3.94% |
| STATE STREET CORP | 02/13/2026 | 2.11 M | $33.05 M | 148.88% | 2.56% |
| AISLING CAPITAL MANAGEMENT LP | 02/10/2026 | 1.47 M | $23.09 M | 0.00% | 1.79% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 1.33 M | $20.85 M | 124.07% | 1.61% |
| FMR LLC | 02/17/2026 | 1.30 M | $20.39 M | -53.77% | 1.58% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.20 M | $18.90 M | 4.63% | 1.46% |
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 1.17 M | $18.40 M | 100.00% | 1.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 1.03 M | $16.14 M | 48.08% | 1.25% |
| BRAIDWELL LP | 02/17/2026 | 948.32 K | $14.87 M | 100.00% | 1.15% |
| MORGAN STANLEY | 02/13/2026 | 805.53 K | $12.63 M | 24.85% | 0.98% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 785.06 K | $12.31 M | 9.45% | 0.95% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 775.00 K | $12.15 M | -3.13% | 0.94% |
| ALPHABET INC. | 02/13/2026 | 744.95 K | $11.68 M | -49.12% | 0.90% |
| PARKWOOD LLC | 02/17/2026 | 708.00 K | $11.10 M | 0.00% | 0.86% |
| NORTHERN TRUST CORP | 02/17/2026 | 697.03 K | $10.93 M | -5.89% | 0.85% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 568.37 K | $8.91 M | -10.09% | 0.69% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 523.38 K | $8.21 M | 45.85% | 0.64% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 448.71 K | $7.04 M | 17.08% | 0.54% |
| MARSHALL WACE, LLP | 02/13/2026 | 398.89 K | $6.25 M | -55.82% | 0.48% |
| INVESCO LTD. | 02/19/2026 | 362.21 K | $5.68 M | 269.99% | 0.44% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 307.65 K | $4.82 M | 100.00% | 0.37% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 295.88 K | $4.64 M | 192.53% | 0.36% |
| NUVEEN, LLC | 02/12/2026 | 285.86 K | $4.48 M | 177.62% | 0.35% |
| NEXTECH INVEST, LTD. | 02/17/2026 | 279.24 K | $4.38 M | 100.00% | 0.34% |
| EMPOWERED FUNDS, LLC | 02/18/2026 | 278.08 K | $4.36 M | 217.98% | 0.34% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 247.86 K | $3.88 M | 21.77% | 0.30% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 223.57 K | $3.51 M | -17.09% | 0.27% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 215.75 K | $3.38 M | 0.00% | 0.26% |
| TD ASSET MANAGEMENT INC | 02/10/2026 | 213.46 K | $3.35 M | 24.05% | 0.26% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 200.00 K | $3.14 M | 100.00% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 173.30 K | $2.72 M | -7.22% | 0.21% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 162.70 K | $2.55 M | -5.41% | 0.20% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 149.71 K | $2.35 M | 100.00% | 0.18% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 148.06 K | $2.32 M | -6.60% | 0.18% |
| ATOM INVESTORS LP | 02/17/2026 | 137.26 K | $2.15 M | 100.00% | 0.17% |
| JANE STREET GROUP, LLC | 02/12/2026 | 137.05 K | $2.15 M | -55.37% | 0.17% |
| BARCLAYS PLC | 02/13/2026 | 135.98 K | $2.13 M | 86.39% | 0.17% |
| J. GOLDMAN & CO LP | 02/17/2026 | 135.00 K | $2.12 M | 100.00% | 0.16% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/13/2026 | 134.67 K | $2.15 M | 13.76% | 0.16% |
| UBS GROUP AG | 01/29/2026 | 123.00 K | $1.93 M | 70.61% | 0.15% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 122.16 K | $1.92 M | 100.00% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 112.70 K | $1.77 M | -6.78% | 0.14% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Monte Rosa Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 209 institutional investors and hedge funds held shares of Monte Rosa Therapeutics Inc. The most heavily invested institutionals were:
Versant Venture Management, LLC: 3.18 M
Aisling Capital Management LP: 1.56 M
DIMENSIONAL FUND ADVISORS LP: 1.04 M
Alphabet Inc.: 684,275
VANGUARD FIDUCIARY TRUST CO: 407,078
Allspring Global Investments Holdings, LLC: 392,227
78.24% of Monte Rosa Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 67.74 M shares in the last 24 months. This purchase volume represents approximately $1.20 B in transactions.